Litigation Details for BAUSCH HEALTH COMPANIES INC. v. ACTAVIS LABORATORIES FL, INC. (D.N.J. 2016)
✉ Email this page to a colleague
BAUSCH HEALTH COMPANIES INC. v. ACTAVIS LABORATORIES FL, INC. (D.N.J. 2016)
| Docket | ⤷ Start Trial | Date Filed | 2016-12-06 |
| Court | District Court, D. New Jersey | Date Terminated | 2019-12-03 |
| Cause | 15:1126 Patent Infringement | Assigned To | Stanley R. Chesler |
| Jury Demand | None | Referred To | Cathy L. Waldor |
| Parties | BAUSCH HEALTH COMPANIES INC | ||
| Patents | 10,307,417; 6,559,158; 8,420,663; 8,524,276; 8,956,651; 9,180,125; 9,314,461 | ||
| Attorneys | GENNA AUTUMN CONTI | ||
| Firms | Law Office of Jason B. Lattimore, Esq. | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in BAUSCH HEALTH COMPANIES INC. v. ACTAVIS LABORATORIES FL, INC.
The small molecule drug covered by the patents cited in this case is ⤷ Start Trial .
Details for BAUSCH HEALTH COMPANIES INC. v. ACTAVIS LABORATORIES FL, INC. (D.N.J. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2016-12-06 | External link to document | |||
| 2016-12-05 | 1 | United States Patent Nos. 8,420,663 (“the ’663 patent”); 8,524,276 (“the ’276 patent”); 8,956,651 (“…. 208271, the ’663 patent, ’276 patent, ’651 patent, ’125 patent, and ’461 patent are listed in the FDA…related to the ’663 patent, ’276 patent, ’651 patent, ’125 patent, or ’461 patent. 30. Upon information…expiration of the ’663 patent, ’276 patent, ’651 patent, ’125 patent, and ’461 patent or such later date …17 PageID: 16 patent, ’276 patent, ’651 patent, ’125 patent, and ’461 patent or such later date | External link to document | |
| 2016-12-05 | 180 | Letter | asserting claims for infringement of U.S. Patent No. 10,307,417. (DENI, WILLIAM) (Entered: 06/14/2019) …2016 3 December 2019 2:16-cv-09038 830 Patent None District Court, D. New Jersey | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
